{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:30:02Z","timestamp":1792506602131,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.neuropharm.2015.08.040","type":"journal-article","created":{"date-parts":[[2015,8,29]],"date-time":"2015-08-29T09:34:44Z","timestamp":1440840884000},"page":"650-657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["PcTx1 affords neuroprotection in a conscious model of stroke in hypertensive rats via selective inhibition of ASIC1a"],"prefix":"10.1016","volume":"99","author":[{"given":"Claudia A.","family":"McCarthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lachlan D.","family":"Rash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ir\u00e8ne R.","family":"Chassagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn F.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Widdop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neuropharm.2015.08.040_bib1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1113\/jphysiol.2002.020297","article-title":"Modulation of ASIC channels in rat cerebellar Purkinje neurons by ischaemia-related signals","volume":"543","author":"Allen","year":"2002","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2015.08.040_bib2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature11375","article-title":"Structural plasticity and dynamic selectivity of acid-sensing ion channel\u2013spider toxin complexes","volume":"489","author":"Baconguis","year":"2012","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.neuropharm.2015.08.040_bib3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.tips.2008.02.003","article-title":"Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke","volume":"29","author":"Besancon","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2015.08.040_bib40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0165-0270(00)00278-8","article-title":"A novel, rapid, computerized method for quantitation of neuronal damage in a rat model of stroke","volume":"102","author":"Callaway","year":"2000","journal-title":"J Neurosci. Methods"},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2015.08.040_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.febslet.2004.07.019","article-title":"Isolation and characterization of psalmopeotoxin I and II: two novel antimalarial peptides from the venom of the tarantula Psalmopoeus cambridgei","volume":"572","author":"Choi","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2015.08.040_bib5","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/ncomms1917","article-title":"Structure of the acid-sensing ion channel 1 in complex with the gating modifier psalmotoxin 1","volume":"3","author":"Dawson","year":"2012","journal-title":"Nat. Commun."},{"issue":"33","key":"10.1016\/j.neuropharm.2015.08.040_bib6","doi-asserted-by":"crossref","first-page":"25116","DOI":"10.1074\/jbc.M003643200","article-title":"Isolation of a tarantula toxin specific for a class of proton-gated Na+ channels","volume":"275","author":"Escoubas","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"issue":"6","key":"10.1016\/j.neuropharm.2015.08.040_bib7","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.toxicon.2006.01.018","article-title":"Venom landscapes: mining the complexity of spider venoms via a combined cDNA and mass spectrometric approach","volume":"47","author":"Escoubas","year":"2006","journal-title":"Toxicon"},{"issue":"6","key":"10.1016\/j.neuropharm.2015.08.040_bib8","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1161\/STROKEAHA.108.541128","article-title":"Update of the stroke therapy academic industry roundtable preclinical recommendations","volume":"40","author":"Fisher","year":"2009","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.neuropharm.2015.08.040_bib9","first-page":"73","article-title":"Structure, function, and pharmacology of acid-sensing ion channels (ASICs): focus on ASIC1a","volume":"2","author":"Gr\u00fcnder","year":"2010","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.08.040_bib10","series-title":"Spider Ecophysiology","first-page":"203","article-title":"The neurotoxic mode of action of venoms from the spider family theraphosidae","author":"Herzig","year":"2013"},{"issue":"53","key":"10.1016\/j.neuropharm.2015.08.040_bib11","doi-asserted-by":"crossref","first-page":"41852","DOI":"10.1074\/jbc.M110.171330","article-title":"Identification of a calcium permeable human acid-sensing ion channel 1 transcript variant","volume":"285","author":"Hoagland","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"issue":"11","key":"10.1016\/j.neuropharm.2015.08.040_bib12","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1134\/S0006297908110011","article-title":"Role of acidosis, NMDA receptors, and acid-sensitive ion channel 1a (ASIC1a) in neuronal death induced by ischemia","volume":"73","author":"Isaev","year":"2008","journal-title":"Biochem. (Mosc)"},{"key":"10.1016\/j.neuropharm.2015.08.040_bib13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev-ento-120811-153650","article-title":"Spider-venom peptides: structure, pharmacology, and potential for control of insect pests","volume":"58","author":"King","year":"2013","journal-title":"Annu. Rev. Entomol."},{"key":"10.1016\/j.neuropharm.2015.08.040_bib14","doi-asserted-by":"crossref","first-page":"e63865","DOI":"10.1371\/journal.pone.0063865","article-title":"Production of recombinant disulfide-rich venom peptides for structural and functional analysis via expression in the periplasm of E. coli","volume":"8","author":"Klint","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.neuropharm.2015.08.040_bib15","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0166-2236(03)00210-8","article-title":"The ASICs: signaling molecules? Modulators?","volume":"26","author":"Krishtal","year":"2003","journal-title":"Trends Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2015.08.040_bib16","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/jcbfm.2010.30","article-title":"Acid-sensing ion channels in acidosis-induced injury of human brain neurons","volume":"30","author":"Li","year":"2010","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"issue":"4","key":"10.1016\/j.neuropharm.2015.08.040_bib17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1179\/1743132812Y.0000000020","article-title":"Neuroprotection targeting ischemic penumbra and beyond for the treatment of ischemic stroke","volume":"34","author":"Liu","year":"2012","journal-title":"Neurol. Res."},{"issue":"6","key":"10.1016\/j.neuropharm.2015.08.040_bib18","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1161\/HYPERTENSIONAHA.112.199646","article-title":"Angiotensin II type 2 receptor stimulation initiated after stroke causes neuroprotection in conscious rats","volume":"60","author":"McCarthy","year":"2012","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.neuropharm.2015.08.040_bib19","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/STROKEAHA.108.531509","article-title":"Angiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of stroke","volume":"40","author":"McCarthy","year":"2009","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.neuropharm.2015.08.040_bib20","doi-asserted-by":"crossref","first-page":"e95762","DOI":"10.1371\/journal.pone.0095762","article-title":"Direct angiotensin AT2 receptor stimulation using a novel AT2 receptor agonist, compound 21, evokes neuroprotection in conscious hypertensive rats","volume":"9","author":"McCarthy","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.neuropharm.2015.08.040_bib21","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1113\/expphysiol.2009.047936","article-title":"Candesartan pretreatment is cerebroprotective in a rat model of endothelin-1-induced middle cerebral artery occlusion","volume":"94","author":"Mecca","year":"2009","journal-title":"Exp. Physiol."},{"issue":"7\u20138","key":"10.1016\/j.neuropharm.2015.08.040_bib22","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.neuropharm.2010.08.015","article-title":"Neuroprotective effect of flurbiprofen in focal cerebral ischemia: the possible role of ASIC1a","volume":"59","author":"Mishra","year":"2010","journal-title":"Neuropharmocology"},{"key":"10.1016\/j.neuropharm.2015.08.040_bib23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.brainres.2011.03.011","article-title":"The neuroprotective effects of NMDAR antagonist, ifenprodil and ASIC1a inhibitor, flurbiprofen on post-ischemic cerebral injury","volume":"1389","author":"Mishra","year":"2011","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2015.08.040_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2010.07.002","article-title":"The science of stroke: mechanisms in search of treatments","volume":"67","author":"Moskowitz","year":"2010","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.neuropharm.2015.08.040_bib25","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/labinvest.3700325","article-title":"Increased angiopoietin2 expression is associated with endothelial apoptosis and blood-brain barrier breakdown","volume":"85","author":"Nag","year":"2005","journal-title":"Lab. Invest."},{"issue":"1","key":"10.1016\/j.neuropharm.2015.08.040_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12975-013-0319-5","article-title":"Translational strategies for neuroprotection in ischemic stroke\u2014focusing on acid-sensing ion channel 1a","volume":"5","author":"O'Bryant","year":"2014","journal-title":"Transl. Stroke Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2015.08.040_bib27","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.jcbfm.9600559","article-title":"In\u00a0vivo and in\u00a0vitro characterization of a novel neuroprotective strategy for stroke: ischemic postconditioning","volume":"28","author":"Pignataro","year":"2008","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"issue":"1","key":"10.1016\/j.neuropharm.2015.08.040_bib28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/brain\/awl325","article-title":"Prolonged activation of ASIC1a and the time window for neuroprotection in cerebral ischaemia","volume":"130","author":"Pignataro","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2015.08.040_bib29","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1124\/mol.111.072207","article-title":"A\u00a0dynamic pharmacophore drives the interaction between psalmotoxin-1 and the putative drug target acid-sensing ion channel 1a","volume":"80","author":"Saez","year":"2011","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2015.08.040_bib30","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/anie.201308898","article-title":"Chemical synthesis, 3D structure, and ASIC binding site of the toxin mambalgin-2","volume":"53","author":"Schroeder","year":"2014","journal-title":"Angew. Chem."},{"issue":"9","key":"10.1016\/j.neuropharm.2015.08.040_bib31","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nature05285","article-title":"Spider toxins activate the capsaicin receptor to produce inflammatory pain","volume":"444","author":"Siemens","year":"2006","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.neuropharm.2015.08.040_bib32","doi-asserted-by":"crossref","first-page":"8026","DOI":"10.1523\/JNEUROSCI.21-20-08026.2001","article-title":"Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors","volume":"21","author":"Voilley","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.08.040_bib33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.brainres.2011.01.041","article-title":"Cleaved caspase-3 expression after experimental stroke exhibits different phenotypes and is predominantly non-apoptotic","volume":"1381","author":"Wagner","year":"2011","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2015.08.040_bib34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/jnr.22742","article-title":"High doses of salicylate and aspirin are inhibitory on acid-sensing ion channels and protective against acidosis-induced neuronal injury in the rat cortical neuron","volume":"90","author":"Wang","year":"2012","journal-title":"J.\u00a0Neurosci. Res."},{"issue":"10","key":"10.1016\/j.neuropharm.2015.08.040_bib35","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.tins.2006.06.014","article-title":"Acid-sensing ion channels: advances, questions and therapeutic opportunities","volume":"29","author":"Wemmie","year":"2006","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2015.08.040_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1326-6-11","article-title":"Pathophysiology, treatment, and animal and cellular models of human ischemic stroke","volume":"6","author":"Woodruff","year":"2011","journal-title":"Mol. Neurodegener."},{"issue":"5","key":"10.1016\/j.neuropharm.2015.08.040_bib37","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1476-5381.2011.01487.x","article-title":"Sinomenine protects against ischaemic brain injury: involvement of co-inhibition of acid-sensing ion channel 1a and L-type calcium channels","volume":"164","author":"Wu","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.08.040_bib38","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.2741\/2154","article-title":"Acid sensing ion channels\u2014novel therapeutic targets for ischemic brain injury","volume":"12","author":"Xiong","year":"2007","journal-title":"Front. Biosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2015.08.040_bib39","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2004.08.026","article-title":"Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels","volume":"118","author":"Xiong","year":"2004","journal-title":"Cell"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2015.08.040_bib41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0006-8993(88)90036-4","article-title":"Behavioural changes after focal cerebral ischemia by left middle cerebral artery occlusion in rats","volume":"452","author":"Yamamoto","year":"1988","journal-title":"Brain Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081530085X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081530085X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T20:24:14Z","timestamp":1567110254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839081530085X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":41,"alternative-id":["S002839081530085X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.08.040","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PcTx1 affords neuroprotection in a conscious model of stroke in hypertensive rats via selective inhibition of ASIC1a","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.08.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}